Post COVID-19 transverse myelitis; a case report with review of literature

• Published in: Annals of medicine and surgery 2021-09, Vol.69, p.102749, Article 102749
• Main Authors: Ahmad, Shwan Abubakr, Salih, Karokh H., Ahmed, Shaho Fatah, Kakamad, Fahmi H., Salh, Abdulwahid M., Hassan, Marwan Nasih, Mohammed, Karukh K., Mohammed, Shvan H., Salih, Rawezh Q., Hussein, Dahat A.
• Format: Article
• Language: English
• Subjects: Case Report; Corona virus disease 2019; Neurological dysfunction; SARS-CoV-2
• ISSN: 2049-0801; 2049-0801
• DOI: 10.1016/j.amsu.2021.102749

Coronavirus disease 2019 (COVID-19) has emerged as severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). Recently, various complications have been reported. The aim of the current study is to report a rare case of transverse myelitis after recovering from COVID-19. A 34-year-old lady, presented with inability to walk for one day duration due to the lower limb weakness. After two weeks from the recovery of COVID-19; she developed progressive intermittent leg pain, paresthesia and weakness on both sides. Brain and cervical MRI showed evidence of a short segment inflammatory enhancing lesion at upper cervical region (at C1 level). The patient was treated conservatively. Transverse myelitis has many different causes, it occurs as an autoimmune phenomenon post-infection and vaccination, or it may result from direct infection or acquired demyelinating disease like multiple sclerosis. Although it is a sporadic finding, SARS-CoV-2 can cause transverse myelitis. The condition responds to medical therapy. •Coronavirus disease 2019 has emerged as severe acute respiratory syndrome coronavirus 2.•Transverse myelitis (TM) is a very rare neurological complication of COVID-19 disease.•In this report a rare case of post-COVID19 transverse myelitis presented.